Exploring Reasons For Starting Antiretroviral Treatment Early Among Patients In South Africa Reasons for starting antiretroviral treatment early
Main Article Content
Abstract
All people living with HIV (PLHIV), regardless of CD4 count or clinical stage, are eligible for immediate initiation of antiretroviral therapy (ART) under the Universal Test and Treat (UTT) approach. Although a high proportion of individuals have been tested, diagnosed, and initiated on ART, retention in HIV care remains a significant challenge. An exploratory qualitative study design was employed among PLHIV enrolled in the UTT programme in the Ekurhuleni District, located east of Johannesburg in Gauteng Province, South Africa. In-depth interviews were conducted with 26 PLHIV aged 18 years and older who had initiated ART and had been on treatment for at least 6–12 months. All interviews were audio-recorded, transcribed verbatim, managed using NVivo version 12 software, and analysed thematically. Five major themes emerged regarding reasons for early ART initiation: (1) fears and doubts about starting ART, (2) motivation to initiate ART early, (3) anticipated benefits of early ART initiation, (4) perceptions of ART in comparison to basic needs and other treatments, and (5) perceptions regarding discontinuation of ART. The finding found that public awareness, continuous counselling and support for PLHIV are needed to increase UTT uptake and retain those already in HIV care.
Keywords: Benefits of starting ART, Fear, Motivation, Public Awareness
Downloads
Article Details
Copyright (c) 2026 Mamokete Catherine Moloto, Prof Mathildah, Muhammad Hoque

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Agustin, D.A., Prasetyo, A.A. and Murti, B. (2018). A Path Analysis on Adherence to Antiretroviral Therapy among HIV/ AIDS Patients at Dr Moewardi Hospital, Surakarta using Health Belief Model. Journal of Health Promotion and Behavior. 03(01): pp.48–55. DOI: https://doi.org/10.26911/thejhpb.2018.03.01.05
Boyd, M., Boffito, M., Castagna, A. and Estrada, V. (2019). Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps. HIV Medicine. 20(S1): pp.3–11. DOI: https://doi.org/10.1111/hiv.12708
Chadambuka, A., Katirayi, L., Muchedzi, A., Tumbare, E., Musarandega, R., Mahomva, A.I. and Woelk, G. (2018). Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study. BMC Public Health. 18(1): p.57. DOI: https://doi.org/10.1186/s12889-017-4611-2
Dessalegn, N.G., Hailemichael, R.G., Shewa-amare, A., Sawleshwarkar, S., Lodebo, B., Amberbir, A. and Hillman, R.J. (2019). HIV Disclosure: HIV-positive status disclosure to sexual partners among individuals receiving HIV care in Addis Ababa, Ethiopia. PLOS ONE. 14(2). pp. 1-17. DOI: https://doi.org/10.1371/journal.pone.0211967
Horter, S., Thabede, Z., Dlamini, V., Bernays, S., Stringer, B., Mazibuko, S., Dube, L., Rusch, B. and Jobanputra, K. (2017). Life is so easy on ART, once you accept it: Acceptance, denial and linkage to HIV care in Shiselweni, Swaziland. Social Science and Medicine, pp. 52-59. DOI: https://doi.org/10.1016/j.socscimed.2017.01.006
Horter, S., Wringe, A., Thabede, Z., Dlamini, V., Kerschberg, B., Pasiparime, M., Lukhele, N., Rusch, B., and Seeley, J. (2019).” It is making any difference.” A qualitative study examining the treatment taking experiences of asymptomatic people living with HIV in the context of Treat all in Eswatini. Journal of the International AIDS Society, pp. 1-6. DOI: https://doi.org/10.1002/jia2.25220
Kim, M.H., Zhou, A., Mazenga, A., Ahmed, S., Markham, C., Zomba, G., Simon, K., Kazembe, P.N. and Abrams, E.L. (2016). Why did I stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi. Public Library of Science, 11(2), pp. 1-16. DOI: https://doi.org/10.1371/journal.pone.0149527
Koole, O., Tsui, S., Wabwire‐Mangen, F., Kwesigabo, G., Menten, J., Mulenga, M., Auld, A., Agolory, S., Mukadi, Y.D., Colebunders, R. and Bangsberg, D.R. (2014). Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Tropical Medicine & International Health, 19(12), pp.1397-1410. DOI: https://doi.org/10.1111/tmi.12386
Nhassengo, Cataldo, F., Magaco, A., Hoffman, R.M., Neuru. L., Saide. M., Cuco, R., Hoek, R., Mbofana, F., Couto, A., Gudo, E., Chicumbe, S. and Dove, K. (2018). Barriers and facilitators to uptake of Test and Treat in Mozambique: A qualitative study on patients and provider perceptions. Public Library of Science, 13(12). pp 1-17. DOI: https://doi.org/10.1371/journal.pone.0205919
Rodger, A.J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Van Lunzen, J.,Corbbelli, G.M. and Estrada, V. ( 2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), pp.171-181. DOI: https://doi.org/10.1001/jama.2016.5148
Shabalala, F., Vernooi, E., Pell, C., Simelane, N., Masilela, N., Spiegelman, D., Chai, B., Khan, S. and Reis, R. (2018). Understanding reasons for discontinued Antiretroviral treatment among clients in test and treat: a qualitative study in Swaziland. Journal of International Society, pp. 53-58. DOI: https://doi.org/10.1002/jia2.25120
Simelela, N. and Venter, W.D.F. (2014). A brief history of South Africa’s response to AIDS. South African Medical Journal. 104(4): pp.249-251. DOI: https://doi.org/10.7196/SAMJ.7700
UNAIDS (2020). Making the end of AIDS real: consensus building around what we mean by “epidemic control”. Geneva. Accessed on 22 October 2020 at www.unaids.org/em/resources/presscentre/.
WHO (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV: recommendation for a public health approach, 2nd edition, Geneva, Switzerland. Available from http:// www.who.int/hiv/pub/guidelines.
Mamokete Catherine Moloto